These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 22897628)

  • 1. Role of C-reactive protein in urological cancers: a useful biomarker for predicting outcomes.
    Saito K; Kihara K
    Int J Urol; 2013 Feb; 20(2):161-71. PubMed ID: 22897628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of C-reactive protein as a biomarker for renal cell carcinoma.
    Saito K; Kihara K
    Expert Rev Anticancer Ther; 2010 Dec; 10(12):1979-89. PubMed ID: 21110763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C-reactive protein in urologic cancers.
    Huang J; Baum Y; Alemozaffar M; Ogan K; Harris W; Kucuk O; Master VA
    Mol Aspects Med; 2015 Nov; 45():28-36. PubMed ID: 25936279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C-reactive protein as a biomarker for urological cancers.
    Saito K; Kihara K
    Nat Rev Urol; 2011 Oct; 8(12):659-66. PubMed ID: 22025173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Utility of the serum CRP value for assessing the prognosis and therapeutic response of urological malignancies].
    Köhler A; Eggers H; Kuczyk MA; Schrader AJ; Steffens S
    Aktuelle Urol; 2013 Nov; 44(6):452-5. PubMed ID: 24258396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic impact of postoperative C-reactive protein level in patients with metastatic renal cell carcinoma undergoing cytoreductive nephrectomy.
    Tatokoro M; Saito K; Iimura Y; Fujii Y; Kawakami S; Kihara K
    J Urol; 2008 Aug; 180(2):515-9. PubMed ID: 18550105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammatory prognostic markers in clear cell renal cell carcinoma - preoperative C-reactive protein does not improve predictive accuracy.
    Bedke J; Chun FK; Merseburger A; Scharpf M; Kasprzyk K; Schilling D; Sievert KD; Stenzl A; Kruck S
    BJU Int; 2012 Dec; 110(11 Pt B):E771-7. PubMed ID: 23134582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoimmune disease and subsequent urological cancer.
    Liu X; Ji J; Forsti A; Sundquist K; Sundquist J; Hemminki K
    J Urol; 2013 Jun; 189(6):2262-8. PubMed ID: 23228387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and external validation of a new outcome prediction model for patients with clear cell renal cell carcinoma treated with nephrectomy based on preoperative serum C-reactive protein and TNM classification: the TNM-C score.
    Iimura Y; Saito K; Fujii Y; Kumagai J; Kawakami S; Komai Y; Yonese J; Fukui I; Kihara K
    J Urol; 2009 Mar; 181(3):1004-12; discussion 1012. PubMed ID: 19150550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating mitochondrial DNA in serum: a universal diagnostic biomarker for patients with urological malignancies.
    Ellinger J; Müller DC; Müller SC; Hauser S; Heukamp LC; von Ruecker A; Bastian PJ; Walgenbach-Brunagel G
    Urol Oncol; 2012; 30(4):509-15. PubMed ID: 20870429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absolute preoperative C-reactive protein predicts metastasis and mortality in the first year following potentially curative nephrectomy for clear cell renal cell carcinoma.
    Johnson TV; Abbasi A; Owen-Smith A; Young A; Ogan K; Pattaras J; Nieh P; Marshall FF; Master VA
    J Urol; 2010 Feb; 183(2):480-5. PubMed ID: 20006861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multicenter prospective study validating the efficacy of a quantitative assessment tool for frailty in patients with urological cancers.
    Soma O; Hatakeyama S; Okamoto T; Fujita N; Hamano I; Tanaka T; Momota M; Yoneyama T; Yamamoto H; Imai A; Yoneyama T; Hashimoto Y; Yoshikawa K; Kawaguchi T; Saitoh H; Nakaji S; Suzuki T; Ohyama C
    Med Oncol; 2019 Sep; 36(10):88. PubMed ID: 31520152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Multiple urologic tumors in autopsy material].
    Tiszlavicz L; Szalay I
    Orv Hetil; 1993 Mar; 134(11):577-81. PubMed ID: 8446411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C-reactive protein: a biomarker of survival in patients with metastatic renal cell carcinoma treated with subcutaneous interleukin-2 based immunotherapy.
    Casamassima A; Picciariello M; Quaranta M; Berardino R; Ranieri C; Paradiso A; Lorusso V; Guida M
    J Urol; 2005 Jan; 173(1):52-5. PubMed ID: 15592024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a new outcome prediction model in carcinoma invading the bladder based on preoperative serum C-reactive protein and standard pathological risk factors: the TNR-C score.
    Gakis G; Todenhöfer T; Renninger M; Schilling D; Sievert KD; Schwentner C; Stenzl A
    BJU Int; 2011 Dec; 108(11):1800-5. PubMed ID: 21507193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of C-reactive protein kinetics on survival of patients with metastatic renal cell carcinoma.
    Saito K; Tatokoro M; Fujii Y; Iimura Y; Koga F; Kawakami S; Kihara K
    Eur Urol; 2009 May; 55(5):1145-53. PubMed ID: 18930583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical analysis of Reg IV in urogenital organs: Frequent expression of Reg IV in prostate cancer and potential utility as serum tumor marker.
    Hayashi T; Matsubara A; Ohara S; Mita K; Hasegawa Y; Usui T; Arihiro K; Norimura S; Sentani K; Oue N; Yasui W
    Oncol Rep; 2009 Jan; 21(1):95-100. PubMed ID: 19082448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation and enrichment of urologic tumor cells in blood samples by a semi-automated CD45 depletion autoMACS protocol.
    Meye A; Bilkenroth U; Schmidt U; Füssel S; Robel K; Melchior AM; Blümke K; Pinkert D; Bartel F; Linne C; Taubert H; Wirth MP
    Int J Oncol; 2002 Sep; 21(3):521-30. PubMed ID: 12168095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of circulating cancer cells by reverse transcription-polymerase chain reaction for uroplakin II in peripheral blood of patients with urothelial cancer.
    Lu JJ; Kakehi Y; Takahashi T; Wu XX; Yuasa T; Yoshiki T; Okada Y; Terachi T; Ogawa O
    Clin Cancer Res; 2000 Aug; 6(8):3166-71. PubMed ID: 10955799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urologic tumors in the Federal Republic of Germany: data on 56,013 cases from hospital cancer registries.
    Fischer CG; Waechter W; Kraus S; Fuentecilla Perez E; Weidner W; Dudeck J
    Cancer; 1998 Feb; 82(4):775-83. PubMed ID: 9477112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.